{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:06:00Z","timestamp":1792875960941,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Academic Center for Dentistry Amsterdam"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>It is not clear whether dopaminergic medication influences bruxism behaviour in patients with Parkinson\u2019s disease (PD). Therefore, the aims are to investigate (i) the prevalence of possible (i.e., self-reported) bruxism (sleep and awake) in PD patients, and (ii) whether the use of dopaminergic medication and other factors (viz., demographic characteristics, PD-related factors, and possible consequences of bruxism) are associated with possible bruxism (sleep or awake).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This study concerns a secondary analysis of an earlier published study. Three hundred ninety-five PD patients (67.9 \u00b1 8.6 years of age; 58.7% males) were included. The levodopa equivalent daily dosage (LEDD) was used as a measure of the dopaminergic medication level. Subsequently, a logistic regression analysis was performed for the dependent variables \u2018awake bruxism\u2019 and \u2018sleep bruxism\u2019, with the following predictors: gender, age, LEDD, time since PD diagnosis, temporomandibular disorder (TMD) pain, jaw locks, and tooth wear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of possible awake and sleep bruxism was 46.0% and 24.3%, respectively. Awake bruxism was associated with sleep bruxism (OR = 8.52; 95% CI 3.56\u201320.40), TMD pain (OR = 4.51; 95% CI 2.31\u20138.79), and tooth wear (OR = 1.87; 95% CI 1.02\u20133.43). Sleep bruxism was associated with tooth wear (OR = 12.49; 95% CI 4.97\u201331.38) and awake bruxism (OR = 9.48; 95% CI 4.24\u201321.19). Dopaminergic medication dose was not associated with awake bruxism (OR = 1.0; 95% CI 0.99\u20131.00) or sleep bruxism (OR = 1.0; 95% CI 0.99\u20131.00).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Bruxism is a common condition in PD patients, but is not associated with the dopaminergic medication dose.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical relevance<\/jats:title>\n                <jats:p>(Oral) health care providers should be alerted about the possibility of sleep and awake bruxism activity in PD patients, along with this activity\u2019s possible negative health outcomes (viz., TMD pain, tooth wear).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00784-020-03566-0","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T07:02:37Z","timestamp":1599894157000},"page":"2545-2553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is dopaminergic medication dose associated with self-reported bruxism in Parkinson\u2019s disease? A cross-sectional, questionnaire-based study"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-5935","authenticated-orcid":false,"given":"M. C.","family":"Verhoeff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koutris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K. A.","family":"van Selms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Brandwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Heres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. W.","family":"Berendse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. D.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lobbezoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"issue":"9996","key":"3566_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"3566_CR2","unstructured":"Eimers M, Bloem B, Munneke M, Sterkenburg P, Tilburg van C (2019) ParkinsonNet in Cijfers"},{"key":"3566_CR3","unstructured":"ParkinsonNet in Cijfers. https:\/\/www.parkinsonnet.nl\/app\/uploads\/2019\/12\/ParkinsonNet-in-cijfers-paramedische-zorg-2010-2018.pdf. Accessed on March 12, 2020"},{"issue":"3","key":"3566_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JPD-130186","volume":"3","author":"D Salat","year":"2013","unstructured":"Salat D, Tolosa E (2013) Levodopa in the treatment of Parkinson\u2019s disease: current status and new developments. J Parkinsons Dis 3(3):255\u2013269. https:\/\/doi.org\/10.3233\/JPD-130186","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"3566_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/joor.12663","volume":"45","author":"F Lobbezoo","year":"2018","unstructured":"Lobbezoo F, Ahlberg J, Raphael KG, Wetselaar P, Glaros AG, Kato T, Santiago V, Winocur E, de Laat A, de Leeuw R, Koyano K, Lavigne GJ, Svensson P, Manfredini D (2018) International consensus on the assessment of bruxism: report of a work in progress. J Oral Rehabil 45(11):837\u2013844. https:\/\/doi.org\/10.1111\/joor.12663","journal-title":"J Oral Rehabil"},{"issue":"7","key":"3566_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/joor.12787","volume":"46","author":"P Wetselaar","year":"2019","unstructured":"Wetselaar P, Vermaire EJH, Lobbezoo F, Schuller AA (2019) The prevalence of awake bruxism and sleep bruxism in the Dutch adult population. J Oral Rehabil 46(7):617\u2013623. https:\/\/doi.org\/10.1111\/joor.12787","journal-title":"J Oral Rehabil"},{"issue":"12","key":"3566_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1046\/j.1365-2842.2001.00839.x","volume":"28","author":"F Lobbezoo","year":"2001","unstructured":"Lobbezoo F, Naeije M (2001) Bruxism is mainly regulated centrally, not peripherally. J Oral Rehabil 28(12):1085\u20131091. https:\/\/doi.org\/10.1046\/j.1365-2842.2001.00839.x","journal-title":"J Oral Rehabil"},{"issue":"7-8","key":"3566_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5177\/ntvt.2017.07\/08.16195","volume":"124","author":"F Lobbezoo","year":"2017","unstructured":"Lobbezoo F, Jacobs R, Laat de A, Aarab G, Wetselaar P, Manfredini D (2017) Chewing on bruxism: associations, consequences and management. Ned Tijdschr Tandheelkd 124(7-8):369\u2013376. https:\/\/doi.org\/10.5177\/ntvt.2017.07\/08.16195","journal-title":"Ned Tijdschr Tandheelkd"},{"issue":"10","key":"3566_CR9","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1177\/00220345960750101401","volume":"75","author":"F Lobbezoo","year":"1996","unstructured":"Lobbezoo F, Soucy JP, Montplaisir JY, Lavigne GJ (1996) Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography. J Dent Res 75(10):1804\u20131810. https:\/\/doi.org\/10.1177\/00220345960750101401","journal-title":"J Dent Res"},{"issue":"1","key":"3566_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mds.870120113","volume":"12","author":"F Lobbezoo","year":"1997","unstructured":"Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY (1997) The effect of the catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial. Mov Disord 12(1):73\u201378. https:\/\/doi.org\/10.1002\/mds.870120113","journal-title":"Mov Disord"},{"key":"3566_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joor.13061","volume":"00","author":"C de Baat","year":"2020","unstructured":"de Baat C, Verhoeff MC, Ahlberg J, Manfredini D, Winocur E, Zweers P, Rozema F, Vissink A, Lobbezoo F (2020) Medications and addictive substances potentially inducing or attenuating sleep bruxism and\/or awake bruxism. J Oral Rehabil 00:1\u201312. https:\/\/doi.org\/10.1111\/joor.13061","journal-title":"J Oral Rehabil"},{"issue":"2","key":"3566_CR12","first-page":"99","volume":"17","author":"E Winocur","year":"2003","unstructured":"Winocur E, Gavish A, Voikovitch M, Emodi-Perlman A, Eli I (2003) Drugs and bruxism: a critical review. J Orofac Pain 17(2):99\u2013111","journal-title":"J Orofac Pain"},{"issue":"9","key":"3566_CR13","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1177\/00220345970760091401","volume":"76","author":"F Lobbezoo","year":"1997","unstructured":"Lobbezoo F, Soucy JP, Hartman NG, Montplaisir JY, Lavigne GJ (1997) Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials. J Dent Res 76(9):1610\u20131614","journal-title":"J Dent Res"},{"issue":"2","key":"3566_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00002826-198704000-00010","volume":"10","author":"M Harris","year":"1987","unstructured":"Harris M, Nora L, Tanner CM (1987) Neuroleptic malignant syndrome responsive to carbidopa\/levodopa: support for a dopaminergic pathogenesis. Clin Neuropharmacol 10(2):186\u2013189. https:\/\/doi.org\/10.1097\/00002826-198704000-00010","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"3566_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.1970.03180010087026","volume":"214","author":"KR Magee","year":"1970","unstructured":"Magee KR (1970) Bruxism related to levodopa therapy. J Am Med Assoc 214(1):147. https:\/\/doi.org\/10.1001\/jama.1970.03180010087026","journal-title":"J Am Med Assoc"},{"issue":"3","key":"3566_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/00002826-200105000-00005","volume":"24","author":"GJ Lavigne","year":"2001","unstructured":"Lavigne GJ, Soucy JP, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY (2001) Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism. Clin Neuropharmacol 24(3):145\u2013149. https:\/\/doi.org\/10.1097\/00002826-200105000-00005","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"3566_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jsr.12440","volume":"26","author":"BJ Cahlin","year":"2017","unstructured":"Cahlin BJ, Hedner J, Dahlstr\u00f6m L (2017) A randomised, open-label, crossover study of the dopamine agonist, pramipexole, in patients with sleep bruxism. J Sleep Res 26(1):64\u201372. https:\/\/doi.org\/10.1111\/jsr.12440","journal-title":"J Sleep Res"},{"issue":"11","key":"3566_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/joor.12697","volume":"45","author":"MC Verhoeff","year":"2018","unstructured":"Verhoeff MC, Lobbezoo F, Wetselaar P, Aarab G, Koutris M (2018) Parkinson\u2019s disease, temporomandibular disorders and bruxism: a pilot study. J Oral Rehabil 45(11):854\u2013863. https:\/\/doi.org\/10.1111\/joor.12697","journal-title":"J Oral Rehabil"},{"issue":"4","key":"3566_CR19","first-page":"306","volume":"20","author":"MR Markiewicz","year":"2006","unstructured":"Markiewicz MR, Ohrbach R, McCall WD (2006) Oral Behaviors Checklist: reliability of performance in targeted waking-state behaviors. J Orofac Pain 20(4):306\u2013316","journal-title":"J Orofac Pain"},{"issue":"1","key":"3566_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.11607\/jop.1151","volume":"28","author":"E Schiffman","year":"2014","unstructured":"Schiffman E, Ohrbach R, Truelove E et al (2014) Diagnostic criteria for temporomandibular disorders (DC\/TMD) for clinical and research applications: recommendations of the International RDC\/TMD Consortium Network* and Orofacial Pain Special Interest Group\u2020. J Oral Facial Pain Headache 28(1):6\u201327. https:\/\/doi.org\/10.11607\/jop.1151","journal-title":"J Oral Facial Pain Headache"},{"issue":"1","key":"3566_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/joor.12340","volume":"43","author":"P Wetselaar","year":"2016","unstructured":"Wetselaar P, Lobbezoo F (2016) The tooth wear evaluation system: a modular clinical guideline for the diagnosis and management planning of worn dentitions. J Oral Rehabil 43(1):69\u201380. https:\/\/doi.org\/10.1111\/joor.12340","journal-title":"J Oral Rehabil"},{"issue":"15","key":"3566_CR22","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25(15):2649\u20132653. https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"issue":"2","key":"3566_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2012.02.029","volume":"34","author":"KTE Olde Dubbelink","year":"2013","unstructured":"Olde Dubbelink KTE, Stoffers D, Deijen JB, Twisk JWR, Stam CJ, Berendse HW (2013) Cognitive decline in Parkinson\u2019s disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol Aging 34(2):408\u2013418. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.02.029","journal-title":"Neurobiol Aging"},{"key":"3566_CR24","unstructured":"Lodder P (2013) To impute or not impute: that\u2019s the question. Methodological Advice 1-7"},{"issue":"4","key":"3566_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/03610911003650383","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Cohen P, Chen S (2010) How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun Stat Simul Comput 39(4):860\u2013864. https:\/\/doi.org\/10.1080\/03610911003650383","journal-title":"Commun Stat Simul Comput"},{"issue":"4","key":"3566_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1447-0594.2009.00538.x","volume":"9","author":"YT Kwak","year":"2009","unstructured":"Kwak YT, Han IW, Lee PH, Yoon JK, Suk SH (2009) Associated conditions and clinical significance of awake bruxism. Geriatr Gerontol Int 9(4):382\u2013390. https:\/\/doi.org\/10.1111\/j.1447-0594.2009.00538.x","journal-title":"Geriatr Gerontol Int"},{"issue":"3","key":"3566_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","volume":"80","author":"TK Khoo","year":"2013","unstructured":"Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, Barker RA, Burn DJ (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276\u2013281. https:\/\/doi.org\/10.1212\/WNL.0b013e31827deb74","journal-title":"Neurology"},{"issue":"4","key":"3566_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/cdoe.12017","volume":"41","author":"MKA Van Selms","year":"2013","unstructured":"Van Selms MKA, Visscher CM, Naeije M, Lobbezoo F (2013) Bruxism and associated factors among Dutch adolescents. Community Dent Oral Epidemiol 41(4):353\u2013363. https:\/\/doi.org\/10.1111\/cdoe.12017","journal-title":"Community Dent Oral Epidemiol"},{"issue":"6","key":"3566_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1034\/j.1600-0528.2002.00007.x","volume":"30","author":"J Ahlberg","year":"2002","unstructured":"Ahlberg J, Rantala M, Savolainen A, Suvinen T, Nissinen M, Sarna S, Lindholm H, Kononen M (2002) Reported bruxism and stress experience. Community Dent Oral Epidemiol 30(6):405\u2013408. https:\/\/doi.org\/10.1034\/j.1600-0528.2002.00007.x","journal-title":"Community Dent Oral Epidemiol"},{"issue":"1","key":"3566_CR30","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.4317\/medoral.18232","volume":"18","author":"J Ahlberg","year":"2013","unstructured":"Ahlberg J, Lobbezoo F, Ahlberg K, Manfredini D, Hublin C, Sinisalo J, Kononen M, Savolainen A (2013) Self-reported bruxism mirrors anxiety and stress in adults. Med Oral Patol Oral Cir Bucal 18(1):e7\u2013e11. https:\/\/doi.org\/10.4317\/medoral.18232","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"3566_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2842.2010.02118.x","volume":"38","author":"E Winocur","year":"2011","unstructured":"Winocur E, Uziel N, Lisha T, Goldsmith C, Eli I (2011) Self-reported bruxism associations with perceived stress, motivation for control, dental anxiety and gagging. J Oral Rehabil 38(1):3\u201311. https:\/\/doi.org\/10.1111\/j.1365-2842.2010.02118.x","journal-title":"J Oral Rehabil"},{"issue":"10","key":"3566_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0954-6111(03)00188-4","volume":"97","author":"B Maria","year":"2003","unstructured":"Maria B, Sophia S, Michalis M, Charalampos L, Andreas P, John ME, Nikolaos SM (2003) Sleep breathing disorders in patients with idiopathic Parkinson\u2019s disease. Respir Med 97(10):1151\u20131157. https:\/\/doi.org\/10.1016\/S0954-6111(03)00188-4","journal-title":"Respir Med"},{"issue":"8","key":"3566_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2842.2008.01875.x","volume":"35","author":"K Ahlberg","year":"2008","unstructured":"Ahlberg K, Savolainen A, Paju S et al (2008) Bruxism and sleep efficiency measured at home with wireless devices. J Oral Rehabil 35(8):567\u2013571. https:\/\/doi.org\/10.1111\/j.1365-2842.2008.01875.x","journal-title":"J Oral Rehabil"},{"key":"3566_CR34","unstructured":"Zorginstituut Nederland. Farmacotherapeutisch Kompas. Ziekte van Parkinson. https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/indicatieteksten\/ziekte_van_parkinson. Accessed March 20, 2020"},{"issue":"5","key":"3566_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/mds.20776","volume":"21","author":"K \u00d8stergaard","year":"2006","unstructured":"\u00d8stergaard K, Sunde NA (2006) Evolution of Parkinson\u2019s disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 21(5):624\u2013631. https:\/\/doi.org\/10.1002\/mds.20776","journal-title":"Mov Disord"},{"issue":"10","key":"3566_CR36","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/brain\/awh571","volume":"128","author":"MC Rodriguez-Oroz","year":"2005","unstructured":"Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, van Blercom N (2005) Bilateral deep brain stimulation in Parkinson\u2019s disease: a multicentre study with 4 years follow-up. Brain 128(10):2240\u20132249. https:\/\/doi.org\/10.1093\/brain\/awh571","journal-title":"Brain"},{"issue":"20","key":"3566_CR37","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa035275","volume":"349","author":"P Krack","year":"2003","unstructured":"Krack P, Batir A, Van Blercom N et al (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. N Engl J Med 349(20):1925\u20131934. https:\/\/doi.org\/10.1056\/NEJMoa035275","journal-title":"N Engl J Med"},{"issue":"3","key":"3566_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3171\/jns.2003.99.3.0489","volume":"99","author":"G Kleiner-Fisman","year":"2003","unstructured":"Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE (2003) Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 99(3):489\u2013495. https:\/\/doi.org\/10.3171\/jns.2003.99.3.0489","journal-title":"J Neurosurg"},{"issue":"4","key":"3566_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00702-019-01997-y","volume":"126","author":"S Zhai","year":"2019","unstructured":"Zhai S, Shen W, Graves SM, Surmeier DJ (2019) Dopaminergic modulation of striatal function and Parkinson\u2019s disease. J Neural Transm (Vienna) 126(4):411\u2013422. https:\/\/doi.org\/10.1007\/s00702-019-01997-y","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"3566_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/00016357.2016.1247465","volume":"75","author":"A Jim\u00e9nez-Silva","year":"2017","unstructured":"Jim\u00e9nez-Silva A, Pe\u00f1a-Dur\u00e1n C, Tobar-Reyes J, Frugone-Zambra R (2017) Sleep and awake bruxism in adults and its relationship with temporomandibular disorders: a systematic review from 2003 to 2014. Acta Odontol Scand 75(1):36\u201358. https:\/\/doi.org\/10.1080\/00016357.2016.1247465","journal-title":"Acta Odontol Scand"},{"key":"3566_CR41","doi-asserted-by":"publisher","unstructured":"Muzalev K, Lobbezoo F, Janal MN, Raphael KG (2017) Interepisode sleep bruxism intervals and myofascial face pain. Sleep 40(8). https:\/\/doi.org\/10.1093\/sleep\/zsx078","DOI":"10.1093\/sleep\/zsx078"},{"key":"3566_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prdoa.2019.11.004","volume":"2","author":"Y-C Tai","year":"2020","unstructured":"Tai Y-C, Lin C-H (2020) An overview of pain in Parkinson\u2019s disease. Clin Park Relat Disord 2:1\u20138","journal-title":"Clin Park Relat Disord"},{"key":"3566_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2019.02.007","volume":"315","author":"RA Domenici","year":"2019","unstructured":"Domenici RA, Campos ACP, Maciel ST, Berzuino MB, Hernandes MS, Fonoff ET, Pagano RL (2019) Parkinson\u2019s disease and pain: modulation of nociceptive circuitry in a rat model of nigrostriatal lesion. Exp Neurol 315:72\u201381. https:\/\/doi.org\/10.1016\/j.expneurol.2019.02.007","journal-title":"Exp Neurol"},{"issue":"2","key":"3566_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.prdoa.2019.11.004","volume":"23","author":"D Manfredini","year":"2009","unstructured":"Manfredini D, Lobbezoo F (2009) Role of psychosocial factors in the etiology of bruxism. J Orofac Pain 23(2):153\u2013166. https:\/\/doi.org\/10.1016\/j.prdoa.2019.11.004","journal-title":"J Orofac Pain"},{"issue":"1","key":"3566_CR45","first-page":"35","volume":"22","author":"A Van\u2019t Spijker","year":"2009","unstructured":"Van\u2019t Spijker A, Rodriguez JM, Kreulen CM, Bronkhorst EM, Bartlett DW, Creugers NHJ (2009) Prevalence of tooth wear in adults. Int J Prosthodont 22(1):35\u201342","journal-title":"Int J Prosthodont"},{"issue":"6","key":"3566_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1159\/000447020","volume":"50","author":"P Wetselaar","year":"2016","unstructured":"Wetselaar P, Vermaire JH, Visscher CM, Lobbezoo F, Schuller AA (2016) The prevalence of tooth wear in the Dutch adult population. Caries Res 50(6):543\u2013550. https:\/\/doi.org\/10.1159\/000447020","journal-title":"Caries Res"},{"issue":"8","key":"3566_CR47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/joor.12807","volume":"46","author":"P Wetselaar","year":"2019","unstructured":"Wetselaar P, Manfredini D, Ahlberg J, Johansson A, Aarab G, Papagianni CE, Reyes Sevilla M, Koutris M, Lobbezoo F (2019) Associations between tooth wear and dental sleep disorders: a narrative overview. J Oral Rehabil 46(8):765\u2013775. https:\/\/doi.org\/10.1111\/joor.12807","journal-title":"J Oral Rehabil"},{"issue":"1","key":"3566_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-017-0904-4","volume":"17","author":"G McLean","year":"2017","unstructured":"McLean G, Hindle JV, Guthrie B, Mercer SW (2017) Co-morbidity and polypharmacy in Parkinson\u2019s disease: insights from a large Scottish primary care database. BMC Neurol 17(1):126. https:\/\/doi.org\/10.1186\/s12883-017-0904-4","journal-title":"BMC Neurol"},{"issue":"5","key":"3566_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.parkreldis.2015.02.005","volume":"21","author":"H Park","year":"2015","unstructured":"Park H, Lee JY, Shin CM, Kim JM, Kim TJ, Kim JW (2015) Characterization of gastrointestinal disorders in patients with parkinsonian syndromes. Parkinsonism Relat Disord 21(5):455\u2013460. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3566_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joor.12011","volume":"40","author":"F Lobbezoo","year":"2013","unstructured":"Lobbezoo F, Ahlberg J, Glaros AG, Kato T, Koyano K, Lavigne GJ, de Leeuw R, Manfredini D, Svensson P, Winocur E (2013) Bruxism defined and graded: an international consensus. J Oral Rehabil 40(1):2\u20134. https:\/\/doi.org\/10.1111\/joor.12011","journal-title":"J Oral Rehabil"},{"issue":"5","key":"3566_CR51","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/joor.12938","volume":"47","author":"D Manfredini","year":"2020","unstructured":"Manfredini D, Ahlberg J, Aarab G, Bracci A, Durham J, Ettlin D, Gallo LM, Koutris M, Wetselaar P, Svensson P, Lobbezoo F (2020) Towards a standardized tool for the assessment of bruxism (STAB) \u2013 overview and general remarks of a multidimensional bruxism evaluation system. J Oral Rehabil 47(5):549\u2013556. https:\/\/doi.org\/10.1111\/joor.12938","journal-title":"J Oral Rehabil"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-020-03566-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T01:05:16Z","timestamp":1631408716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-020-03566-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1007\/s00784-020-03566-0","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the 1964 Helsinki Declaration. Approval was granted by the Medical Ethics Committee of the VU Medical Centre, Amsterdam, The Netherlands (file no. 2015.461; approval date November 26th, 2015).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}